Analysis of sera from SV40-immunized and tumor-bearing hosts for blocking activity and antibody-dependent cellular cytotoxicity.
The role of serum factors in tumor immunity to cells transformed by PARA-(defective SV40)-adenovirus 7 was investigated. It was found that sera from SV40-sensitized hosts did not block the specific cytotoxicity of SV40-sensitized spleen cells for PARA-7 cells. However, such sera could collaborate with nonsensitized spleen cells to produce specific killing. This activity could be absorbed out by PARA-7 cells but not by cells transformed by cytomegalovirus. The activity of sera from hamsters bearing tumor isografts depended upon when, after transplantation, the specimens were obtained. Sera collected greater than or equal to 10 days after grafting completely blocked immune spleen cell cytotoxicity and did not mediate target cell killing in the presence of normal spleen cells. Sera obtained at an earlier time, i.e., 3 to 6 days after transplantation, consistently were active in the antibody-dependent cellular cytotoxicity test and exhibited reduced or no blocking of antibody-independent cellular cytotoxicity. Thus, there appears to be an inverse correlation in the capacity of serum from tumor bearing hosts to block effector cell cytotoxicity and mediate antibody-dependent cellular cytotoxicity.
D000042:Absorption; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis*; D001667:Binding, Competitive; D002471:Cell Transformation, Neoplastic; D006224:Cricetinae; D046508:Culture Techniques; D003587:Cytomegalovirus / Q000276:immunology; D003588:Cytopathogenic Effect, Viral; D003601:Cytotoxicity Tests, Immunologic; D003673:Defective Viruses / Q000276:immunology; D004622:Embryo, Mammalian; D005347:Fibroblasts; D000882:Haplorhini; D007111:Immunity, Cellular; D007114:Immunization; D007668:Kidney; D009374:Neoplasms, Experimental / Q000276:immunology*; D013539:Simian virus 40 / Q000276:immunology*; D018139:Simplexvirus / Q000276:immunology; D014776:Virus Cultivation
D000914:Antibodies, Viral